Information Provided By:
Fly News Breaks for September 4, 2019
HQY
Sep 4, 2019 | 12:25 EDT
Barrington analyst Alexander Paris lowered his price target for HealthEquity to $75 from $100 to account for lower visibility in the near term following last night's Q2 results. The company posted a strong performance across all key metrics, but the stock is trading lower due, in part, to lower near-term visibility given the WageWorks acquisition, Paris tells investors in a research note. He reiterates an Outperform rating on HealthEquity.